New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy

Home > Science Hub > New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy
Back to the list

April 11, 2024

You might also be interested by

CellTalk Blog

This is SPARTA: A Framework for Multiplex Immunofluorescence Analysis

November 13, 2025

More info

Posters

Artificial Intelligence-powered Spatial Analysis of Tumor Microenvironment Identifies Immune Phenotype in Non- Small Cell Lung Cancer, Colorectal Cancer and Urothelial Cancer.

October 30, 2025

More info

Posters

Combining high-plex proteomics with single-cell transcriptomics for deep characterization of antigen-specific T cell responses

October 30, 2025

More info

CellTalk Blog

Understanding the FDA’s Guidance for ADC Development

October 24, 2025

More info